)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
Cue Biopharma
Cue Biopharma (CUE) investor relations material
Cue Biopharma Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary18 Jun, 2026
Company overview and business model
Clinical-stage therapeutics company developing transformative therapies for immunological disorders, with lead asset CUE-221 (anti-IgE monoclonal antibody) in Phase 2 for allergic diseases and Immuno-STATⓇ platform targeting disease-specific T cells.
Entered a global license agreement (excluding Greater China) with Ascendant Health Sciences Ltd. for CUE-221, with exclusive rights to develop, manufacture, and commercialize the asset.
Pipeline includes CUE-401 for autoimmune diseases advancing toward Phase 1, and a focus on Treg-mediated tolerance.
Financial performance and metrics
Paid $15 million upfront for the license, with up to $676.5 million in potential milestone payments and tiered royalties on net sales.
Recurring losses from operations raise substantial doubt about ability to continue as a going concern; additional financing and cost management initiatives are being pursued.
No history of generating commercial revenue and may never achieve profitability.
Use of proceeds and capital allocation
Will not receive proceeds from the resale of shares by the selling stockholder; only nominal proceeds from any cash exercise of pre-funded warrants.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cue Biopharma
- All proposals, including share issuance and the 2026 Stock Plan, were approved by stockholders.CUE
EGM 20264 Jun 2026 - Advancing dual-mechanism immunotherapies with major clinical milestones expected by end of 2026.CUEJefferies Global Healthcare Conference 20263 Jun 2026
- Registering 4.1M shares for resale after $30M private placement; proceeds only from warrant exercises.CUERegistration filing3 Jun 2026
- Approval sought for share issuance, new incentive plan, and meeting adjournment authority.CUEProxy filing21 May 2026
- Revenue up, net loss down, and new financing extends runway into 2027, but capital needs persist.CUEQ1 202614 May 2026
- Shareholders to vote on major share issuance, new incentive plan, and meeting adjournment authority.CUEProxy filing12 May 2026
- All proposals, including a reverse stock split, were approved at the virtual meeting.CUEAGM 202613 Apr 2026
- Advancing to Phase 1, the bifunctional therapy targets autoimmune diseases with strong preclinical data.CUER&D Day 202613 Apr 2026
- Director resignation leads to interim CEO appointment and board size reduction.CUEProxy filing27 Mar 2026
Next Cue Biopharma earnings date
Q2 202612 Aug, 2026
Cue Biopharma
Next Cue Biopharma earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage